---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-013632"
form_type: "8-K"
ticker: "NRXS"
cik: "0001933567"
company_name: "Neuraxis, INC"
filed_at: "2025-06-04T23:59:59+00:00"
generated_at: "2026-05-20T00:22:30.492310+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Neuraxis stockholders approve Series B conversion stock issuance; elect directors

## Summary
- Votes to approve issuance of 20%+ of outstanding common stock upon conversion of Series B Preferred Stock passed with 4.1M for, 129K against, 1.1M broker non-votes.
- All six director nominees elected: Brian Carrico, Dr. Christopher R Brown, Bradley Mitch Watkins, Beth Keyser, Kristen Ferge, Dr. Gilad Aharon.
- Ratification of auditor Rosenberg Rich Baker Berman, P.A. approved with 5.66M votes for.

## SEC filing metadata
- accession: 0001641172-25-013632
- form_type: 8-K
- ticker: NRXS
- cik: 0001933567
- company_name: Neuraxis, INC
- filed_at: 2025-06-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1933567/000164117225013632/0001641172-25-013632-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1933567/000164117225013632/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-013632
- JSON: https://secwatch.observer/filing/0001641172-25-013632.json
- Plain text: https://secwatch.observer/filing/0001641172-25-013632.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.